Table 2:
Province (City) | Sex | Number of studies | Pooled prevalence of urogenital mycoplasmas a(%) (range) | ||||
---|---|---|---|---|---|---|---|
All species | MH | UU | MG | UP b | |||
Tehran | M F |
14 12 |
10.1 (6.2–16.1) 19.6 (15.1–25.1) |
12.6 (6.7–22.6) 17.8 (14.5–21.6) |
11.5 (4.9–25.0) 26.4 (18.6–36.0) |
10.1 (3.3–26.9) 5.2 (2.9–9.2)* |
2.5 (1.0–5.9) NS |
Kerman | M F |
3 2 |
16.2 (11.8–22.0) 13.9 (7.7–23.9) |
18.1 (12.0–26.3) 18.0 (11.6–26.8) * |
NS NS |
13.0 (7.7–21.1)
*
10.0 (5.5–17.6) * |
NS NS |
Ahvaz | M F |
NS 4 |
7.2 (4.8–10.7) |
5.1 (2.9–8.8) |
9.5 (7.6–11.8) |
NS |
NS |
Sanandaj | M F |
NS 4 |
9.2 (2.7–27.1) |
2.9 (0.9–8.6) * |
22.2 (6.2–55.1) |
2.9 (0.9–8.6) * |
NS NS |
Kermanshah |
M F |
NS 1 |
4.9 (2.8–8.7) |
NS |
NS |
4.9 (2.8–8.7) * |
NS NS |
Gorgan | M F |
NS 2 |
7.7 (5.6–10.4) |
7.7 (4.9–11.8) * |
7.7 (4.9–11.8) * |
NS |
NS NS |
Tonekabon | M F |
NS 1 |
22.7 (12.7–37.3) |
NS |
NS |
22.7 (12.7–37.3) * |
NS NS |
Sabzevar | M F |
NS 1 |
2.0 (0.8–5.3) |
NS |
NS |
2.0 (0.8–5.3) * |
NS NS |
Total | M F |
17 27 |
11.1 (7.4–16.4) 12.8 (9.8–16.5) |
15.3 (10.6–21.7) 12.2 (8.8–16.8) |
11.5 (4.9–25) 18.9 (12.7–27.2) |
10.7 (4.6–22.9) 6.2 (3.1–11.8) |
2.5 (1.0–5.9) NS |
M: male; F: female; MH: M. hominis; UU: U. urealyticum; MG: M. genitalium; UP: U. parvum;
Based on random effects, (95% CI);
There was only one article among included studies, investigated the prevalence of U. parvum in males;
There was only one study among included articles in this gender, from this city; NS: no study conducted in this city, about this gender.